Bone Biologics announces 1-for-6 reverse stock split effective June 10, 2025

Bone Biologics Corp

Reverse stock split ratio of 1-for-6, effective 12:01 a.m. ET on June 10, 2025.
Common stock to trade on Nasdaq under symbol BBLG starting June 10; warrants unchanged (BBLGW).
New CUSIP for common stock is 098070600; par value remains $0.001 per share.
Fractional shares rounded up to nearest whole share; authorized shares unchanged.
Proportionate adjustments to exercise prices and shares issuable under warrants and equity awards.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Bone Biologics Corp: Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-6 reverse stock split of common stock (effective 2025-06-10).

Change: charter amendment
Effective: 2025-06-10

Exact text from the filing

On June 5, 2025, Bone Biologics Corporation (the “Company”) filed a Certificate of Amendment to amend its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware. The Certificate of Amendment effects a reverse stock split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a ratio of 1-for-6 shares, effective as of 12:01 a.m. Eastern Time on June 10, 2025 (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

Bone Biologics Corp filing history →

Source: SEC EDGAR

accession 0001641172-25-013937

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.